Ypsomed Holding Stock

Ypsomed Holding ROE 2024

Ypsomed Holding ROE

0.13

Ticker

YPSN.SW

ISIN

CH0019396990

WKN

A0B8VP

In 2024, Ypsomed Holding's return on equity (ROE) was 0.13, a 115.53% increase from the 0.06 ROE in the previous year.

Ypsomed Holding Aktienanalyse

What does Ypsomed Holding do?

Ypsomed Holding AG is a Swiss company specialized in the development and production of medical products. It started in the 1980s when the founder, Willy Michel, established his own company focusing on the production of insulin pens. Today, it has become one of the largest providers of injector systems in Europe. Ypsomed's business model is based on focusing on niche products in medical technology and developing innovative solutions for specific medical problems. It also collaborates closely with leading clinics, research institutions, and other partners to develop new products and improve existing technologies. Ypsomed is divided into different business divisions. One of the largest divisions is Diabetes Care, specializing in the development and production of insulin pens and pumps. Ypsomed is a significant supplier of devices and accessories for some of the world's largest pharmaceutical companies. Another important division of Ypsomed is SelfCare, focused on the development and production of medication delivery systems for self-medication by patients. The offerings range from pen systems to auto-injectors, inhalers, and nasal spray systems. Ypsomed also offers a range of other products, including infection control systems, injection systems for veterinary medicine, and specialty products for wound care. In addition to its products, Ypsomed stands out for its focus on research and development. The company regularly invests in new technologies to find better solutions for medical problems and works closely with leading clinics and research institutions worldwide. Overall, Ypsomed is a leading provider of medical products and solutions for specific medical problems. The company operates in more than 80 countries and has gained a reputation as an innovative partner in the medical technology industry. Ypsomed Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Ypsomed Holding's Return on Equity (ROE)

Ypsomed Holding's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Ypsomed Holding's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Ypsomed Holding's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Ypsomed Holding’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Ypsomed Holding stock

What is the ROE (Return on Equity) of Ypsomed Holding this year?

The ROE of Ypsomed Holding this year is 0.13 undefined.

How has the Return on Equity (ROE) of Ypsomed Holding developed compared to the previous year?

The ROE of Ypsomed Holding has increased by 115.53% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Ypsomed Holding?

A high ROE indicates that Ypsomed Holding generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Ypsomed Holding?

A low ROE can indicate that Ypsomed Holding is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Ypsomed Holding affect the company?

A change in ROE (Return on Equity) of Ypsomed Holding can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Ypsomed Holding?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Ypsomed Holding?

Some factors that can influence Ypsomed Holding's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Ypsomed Holding pay?

Over the past 12 months, Ypsomed Holding paid a dividend of 1 CHF . This corresponds to a dividend yield of about 0.24 %. For the coming 12 months, Ypsomed Holding is expected to pay a dividend of 1.03 CHF.

What is the dividend yield of Ypsomed Holding?

The current dividend yield of Ypsomed Holding is 0.24 %.

When does Ypsomed Holding pay dividends?

Ypsomed Holding pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Ypsomed Holding?

Ypsomed Holding paid dividends every year for the past 0 years.

What is the dividend of Ypsomed Holding?

For the upcoming 12 months, dividends amounting to 1.03 CHF are expected. This corresponds to a dividend yield of 0.24 %.

In which sector is Ypsomed Holding located?

Ypsomed Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ypsomed Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ypsomed Holding from 7/3/2024 amounting to 1 CHF, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Ypsomed Holding pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of Ypsomed Holding in the year 2023?

In the year 2023, Ypsomed Holding distributed 0.65 CHF as dividends.

In which currency does Ypsomed Holding pay out the dividend?

The dividends of Ypsomed Holding are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ypsomed Holding

Our stock analysis for Ypsomed Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ypsomed Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.